The widely accepted therapeutic range for lithium in adults with bipolar disorder is 0.60 to 0.80 mmol/L, measured as a trough serum level drawn roughly 12 hours after the last dose. That single range, however, is a starting point rather than a fixed rule. An international task force reached consensus that the level can be lowered to 0.40–0.60 mmol/L when someone responds well but struggles with side effects, or raised to 0.80–1.00 mmol/L when the response is inadequate and tolerance is good.1PubMed Central. What is the optimal serum level for lithium in the maintenance treatment of bipolar disorder? A systematic review and recommendations from the ISBD/IGSLI Task Force on treatment with lithium What counts as “normal” depends on who you are, what medications you take, how old you are, and even when your blood was drawn.
How the Standard Range Was Decided
Lithium has been used in psychiatry since the late 1940s, yet the optimal serum level for long-term maintenance was debated for decades. The range that most clinicians now use comes from a systematic review and expert consensus by the International Society for Bipolar Disorders and the International Group for the Study of Lithium-Treated Patients. After reviewing the available evidence, the task force settled on 0.60–0.80 mmol/L as the standard maintenance target for most adults. That range represents a balance: high enough to prevent mood episodes in many patients, low enough to keep side effects manageable.
The flexibility built into the recommendation matters. Clinicians are encouraged to individualize the target. For someone who has been stable for years and develops tremor, excessive thirst, or other bothersome effects, dropping to 0.40–0.60 mmol/L may preserve efficacy while relieving symptoms. For someone who keeps relapsing despite adequate adherence, pushing to 0.80–1.00 mmol/L may be worth the tradeoff of closer monitoring and a narrower margin before toxicity.1PubMed Central. What is the optimal serum level for lithium in the maintenance treatment of bipolar disorder? A systematic review and recommendations from the ISBD/IGSLI Task Force on treatment with lithium The result is that two patients on the same drug, both “in range,” can have target levels that differ by a factor of two.
Timing the Blood Draw Makes or Breaks the Number
A lithium level drawn at the wrong time can look falsely high or falsely low, leading to unnecessary dose changes or missed toxicity. The reference ranges used by labs assume the blood was drawn at a specific point in the dosing cycle, usually about 12 hours after the last dose. That 12-hour mark captures the trough, the lowest point the level reaches before the next dose, and it is the standard against which decades of clinical data were generated.2PubMed Central. Serum Lithium Levels: Ideal Time for Sample Collection! Are We Doing it Right?
The situation gets trickier with different dosing schedules. When lithium is taken once daily instead of in divided doses, trough levels should ideally be measured 24 hours after the last dose, because drawing at 12 hours in a once-daily regimen catches the level while it is still falling, not at its true trough.2PubMed Central. Serum Lithium Levels: Ideal Time for Sample Collection! Are We Doing it Right? Extended-release formulations add another wrinkle, since they absorb more slowly and peak later. Research on this topic confirms that 12 hours after the previous dose is still the best draw time for extended-release tablets when comparing results to the standard reference data built from immediate-release studies.3PubMed Central. Optimal timing for lithium levels
If you have ever had a blood draw and the nurse asked when you took your last dose, this is why. A level of 0.9 mmol/L drawn six hours after a dose means something very different from 0.9 mmol/L drawn at the proper trough. Labs do not always flag the timing, so the burden often falls on you and your prescriber to ensure the sample is collected correctly.
Why Older Adults Need Lower Targets
Kidney function declines with age, and since lithium is cleared almost entirely by the kidneys, older adults tend to accumulate higher levels from the same dose. They are also more sensitive to lithium’s neurological side effects. A Delphi survey of experts recommended that adults aged 60 to 79 aim for serum levels of 0.4–0.7 mmol/L, while those 80 and older should stay in the 0.4–0.6 mmol/L range, assuming they are stable and responding well.4PubMed Central. Lithium Therapy in Old Age: Recommendations from a Delphi Survey
A systematic review by an international task force supported these lower targets, concluding that age-related drops in renal clearance and heightened sensitivity to side effects make standard adult ranges inappropriate for older patients. The review called for clinical laboratories to adopt age-specific therapeutic ranges rather than applying a single reference interval across all adults.5PubMed Central. Towards a Safe and Effective Lithium Therapeutic Range for Older Adults With Bipolar Disorder: An ISBD Task Force Systematic Review In practice, many lab printouts still show a single adult range, so an older person seeing a result flagged as “low” might actually be sitting right where they should be.
Lithium Levels During Pregnancy
Pregnancy changes nearly everything about lithium management. Blood volume expands, kidney filtration increases, and the drug’s clearance can rise sharply, meaning levels that were stable before conception may drop too low to prevent relapse. At the same time, lithium carries reproductive risks: a meta-analysis of over 23,000 exposed pregnancies found higher odds of congenital anomalies overall and cardiac anomalies specifically, though the absolute risk remained relatively low.6PubMed. Lithium Exposure During Pregnancy and the Postpartum Period: A Systematic Review and Meta-Analysis of Safety and Efficacy Outcomes The same analysis found that mothers with serum levels below about 0.64 mmol/L and doses under 600 mg per day had more reactive newborns and no increased cardiac malformation risk.
Current guidance recommends more frequent monitoring during pregnancy than usual, with weekly blood draws in the third trimester as the body’s physiology shifts rapidly in the weeks before delivery.7PubMed Central. Lithium during pregnancy and after delivery: a review After delivery, blood volume contracts quickly, and lithium levels can spike. Because the postpartum period carries a very high risk of bipolar relapse, clinicians generally aim for a robust therapeutic level in the weeks after birth while watching closely for toxicity. There is no universal “pregnancy range” printed on lab reports; instead, the target is individualized based on the severity of illness, trimester, and whether the benefits of mood stability outweigh the reproductive risks.
Drugs That Push Lithium Levels Up or Down
Because lithium is cleared almost entirely by the kidneys, anything that changes kidney function or sodium handling can shift lithium levels. The most clinically important offenders fall into a few categories:
- Thiazide diuretics: These have the greatest potential to raise lithium levels, with increases of roughly 25 to 40 percent often seen after starting therapy.
- NSAIDs: Common painkillers like ibuprofen and naproxen reduce kidney blood flow and increase lithium reabsorption, though the degree varies between individuals and between specific drugs.
- ACE inhibitors and ARBs: Both classes of blood-pressure medication can impair lithium clearance and have been linked to toxicity.
- Loop diuretics: These have more modest and variable effects on lithium levels compared to thiazides.
On the other side, caffeine-like compounds and osmotic diuretics tend to increase lithium clearance, which is why some patients notice their levels dip when they ramp up coffee intake.8PubMed. Clinical relevance of drug interactions with lithium The underlying mechanism is that lithium’s reabsorption in the kidney parallels sodium’s: when the body senses low sodium or low fluid volume, it reabsorbs more of both, driving lithium levels higher.9Archives of Clinical Psychiatry. Lithium interactions with non-steroidal anti-inflammatory drugs and diuretics – A review
The practical implication is that any time a new medication is added, especially a diuretic, NSAID, or blood-pressure drug, lithium levels should be rechecked within a week or two.10PubMed Central. Lithium therapy and its interactions Even an over-the-counter painkiller taken for a few days during a headache can nudge the level enough to cause symptoms in someone who normally sits near the top of the range. Dehydration, heavy sweating, and low-salt diets can do the same through the same sodium-conservation pathway.
Kidney Effects Over the Long Haul
The kidneys are the organ that clinicians watch most carefully in long-term lithium therapy. A large retrospective study found that, after adjusting for age, sex, and diabetes, having lithium in the serum was associated with roughly double the risk of developing stage-three chronic kidney disease.11The Lancet. Long-term risks of renal, endocrine, and metabolic side effects of lithium therapy Another study of patients treated for 10 to 29 years reported that about a third showed evidence of chronic kidney impairment, though only around 5 percent fell into the severe category.12PubMed. Effects of 10 to 30 years of lithium treatment on kidney function
Increased urination and thirst, reflecting the kidney’s impaired ability to concentrate urine, is one of the most common early signs. Duration of lithium therapy appears to be the strongest risk factor for this kind of tubular dysfunction, while other conditions like high blood pressure and diabetes compound the risk.13PubMed Central. Key questions on the long term renal effects of lithium: a review of pertinent data The connection between serum levels and kidney harm is not purely binary: higher-than-median lithium concentrations over time are associated with worse outcomes, which is one reason many clinicians aim for the lowest effective level rather than the highest tolerated one.
Thyroid and Parathyroid Effects
Lithium concentrates in the thyroid gland and interferes with hormone release. The same large retrospective study that examined kidney disease found that lithium was linked to more than double the risk of developing hypothyroidism, an effect that held after adjusting for age, sex, and diabetes.14The Lancet. Long-term renal, endocrine, and metabolic effects of lithium therapy: a retrospective cohort analysis Hypothyroidism is generally treatable with thyroid hormone replacement, and it is not usually a reason to stop lithium, but it does require regular monitoring with blood tests.
Less commonly discussed is lithium’s effect on the parathyroid glands, which regulate calcium. Studies have found higher rates of hyperparathyroidism and elevated calcium in people taking lithium, with one cross-sectional study reporting that roughly a quarter of lithium-exposed patients had elevated calcium levels and about 9 percent met criteria for hyperparathyroidism.15PubMed. Lithium-associated hyperparathyroidism and hypercalcaemia: a case-control cross-sectional study Duration of exposure was linked to rising calcium levels, suggesting that longer treatment increases the risk.16PubMed Central. Lithium-Induced Hyperparathyroidism: An Ill-defined Territory Routine calcium and parathyroid hormone checks are part of standard lithium monitoring, though they are sometimes overlooked.
What Happens When Levels Get Too High
Lithium has one of the narrowest therapeutic windows of any commonly prescribed drug. The gap between an effective level and a toxic one is small, which is the whole reason monitoring exists. Mild toxicity typically produces symptoms like increased tremor, nausea, diarrhea, and blurred vision. As levels climb further, neurological symptoms dominate: confusion, unsteady gait, slurred speech, and muscle twitching. At very high levels, seizures, coma, and death become real possibilities.
International toxicology guidelines recommend dialysis when serum lithium exceeds 4 mmol/L in someone with impaired kidney function, decreased consciousness, seizures, or abnormal heart rhythms, and suggest it when levels exceed 5 mmol/L or when confusion is present.17Nephrology Dialysis Transplantation. Should we expand the indications for hemodialysis in lithium intoxications beyond the EXTRIP recommendations? In a large analysis of lithium poisoning cases, following these criteria would have led to dialysis in over half of cases. Among those with chronic toxicity who met both a concentration threshold and a clinical symptom on admission, the majority developed lasting neurological damage, underscoring how quickly outcomes worsen once toxicity sets in.18PubMed Central. Haemodialysis for lithium poisoning: Translating EXTRIP recommendations into practical guidelines
One unsettling reality is that neurotoxicity can occur even when serum levels remain within the therapeutic range. Risk factors include advanced age, kidney impairment, and use of other medications that affect the central nervous system.19PubMed Central. Lithium-related neurotoxicity despite serum concentrations in the therapeutic range: risk factors and diagnosis This is part of why a “normal” lithium level on paper does not always mean a person is toxicity-free.
Why Serum Levels Do Not Tell the Whole Story
The number on your lab report reflects how much lithium is floating in your blood plasma. But lithium’s effects happen inside cells, particularly in the brain, and the relationship between serum levels and brain concentrations is less tidy than you might expect. A magnetic resonance spectroscopy study found that the correlation between serum and brain lithium was strong across a broad range of levels but became much weaker when restricted to patients whose serum levels fell within the standard 0.6–1.0 mmol/L therapeutic window.20PubMed. Variability of brain lithium levels during maintenance treatment: a magnetic resonance spectroscopy study In other words, two people with the same serum level can have meaningfully different amounts of lithium in their brains. The researchers suggested this variability could help explain why some patients relapse despite “adequate” serum levels.
Age plays a role too. A study using the same imaging technique found that children and adolescents had lower brain-to-serum lithium ratios than adults, averaging about 0.58 compared to 0.92 in adults, with the ratio increasing as age increased.21PubMed Central. Brain-to-Serum Lithium Ratio and Age: An In Vivo Magnetic Resonance Spectroscopy Study This raises the possibility that younger patients may need higher serum levels to achieve equivalent brain exposure, though clinical guidelines have not yet formally incorporated this finding.
Red blood cell lithium concentration has been explored as a complementary measure. Because lithium accumulates inside red blood cells more slowly than in plasma, the ratio between the two compartments may reflect how well the drug is penetrating tissues. Early research found that patients who responded well to lithium had higher red-blood-cell-to-plasma ratios after treatment began.22PubMed. Lithium distribution in mania: plasma and red blood cell lithium, clinical state, and monoamine metabolites during lithium treatment The ratio has also shown promise as a marker for detecting toxicity that serum levels alone might miss.23PubMed. Comparison of lithium concentrations in red blood cells and plasma in samples collected for TDM, acute toxicity, or acute-on-chronic toxicity A systematic review concluded that red blood cell lithium concentration could be useful for tolerance monitoring, but the data remain too patchy and inconsistent for it to replace standard serum testing.24PubMed Central. Relevance of red blood cell Lithium concentration in the management of Lithium-treated bipolar and unipolar disorders: a systematic narrative review
Lab Equipment Matters More Than You Would Think
Even the machine that runs your lithium level introduces some variability. A study comparing eight different laboratory analyzers found that precision was generally good, with most instruments producing results within 5 percent of each other, but not all did equally well. Some analyzers showed interference from other drugs the patient might be taking, and calcium, sodium, and potassium levels in the sample could throw off readings on certain platforms. The mean differences between analyzers ranged from about -0.13 mmol/L to +0.08 mmol/L when compared against a reference method.25Clinical Chemistry. Lithium determinations evaluated in eight analyzers A discrepancy of 0.1 mmol/L might sound trivial, but in a drug where the therapeutic range spans only 0.2 to 0.4 mmol/L, it is enough to shift a result from “in range” to “below range” or vice versa.
The takeaway is not that lithium monitoring is unreliable, but that small fluctuations between tests do not always mean your dose needs changing. Clinicians who manage lithium frequently learn to interpret trends rather than single data points, and they try to use the same lab for serial measurements to minimize machine-to-machine variation.
Genetics and Individual Response
Why some people with bipolar disorder respond brilliantly to lithium while others get little benefit at the same serum level has long been a puzzle. Genetics is part of the answer. Research has identified several gene variants associated with lithium response, particularly in pathways involving brain-derived neurotrophic factor (BDNF), dopamine receptors, and a signaling chain known as the AKT1/GSK3B pathway. In one study, certain variants in the AKT1 gene predicted better response, while variants in BDNF, a dopamine receptor gene, and GSK-3β were linked to poorer outcomes.26PubMed Central. Genetic predictors of lithium response in an ethiopian cohort of patients with bipolar disorder
Other work has taken a broader approach, using polygenic risk scores that aggregate the influence of thousands of genetic variants at once. One study found that combining risk scores for schizophrenia and depression improved the ability to predict who would respond well to lithium, more so than a bipolar disorder risk score alone.27Translational Psychiatry. Combining schizophrenia and depression polygenic risk scores improves the genetic prediction of lithium response in bipolar disorder patients None of this is ready for routine clinical use yet; no one is running a genetic panel to decide your lithium dose. But it helps explain why the “right” serum level varies so much between individuals and why some patients do well at the bottom of the range while others need the top.
Trace Lithium in Drinking Water
Lithium occurs naturally in groundwater at concentrations vastly lower than therapeutic doses, typically micrograms per liter rather than the milligrams per liter seen in treated patients. Even so, a growing body of ecological research has found an inverse relationship between lithium levels in public water supplies and local suicide rates. A meta-analysis of these studies reported a consistent protective association between higher lithium in drinking water and lower suicide mortality.28PubMed. Association between naturally occurring lithium in drinking water and suicide rates: systematic review and meta-analysis of ecological studies One study went further, finding that the inverse link was strongest in areas that also had higher rates of affective disorders, suggesting that trace lithium may exert a measurable mood-stabilizing effect specifically in vulnerable populations.29PubMed. Association between lithium levels in drinking water and suicide rates: Role of affective disorders
These findings have sparked debate about whether lithium should be added to water supplies the way fluoride is added for dental health, though no jurisdiction has acted on the idea. The concentrations involved are thousands of times lower than psychiatric doses, and the studies are ecological, meaning they compare regions rather than tracking individuals. Still, the consistency of the signal across multiple countries and study designs is hard to dismiss entirely. It is a reminder that lithium is not just a psychiatric medication but a naturally occurring element whose biological effects operate across a surprisingly wide range of exposures.30PubMed Central. Lithium in drinking water and suicide mortality: interplay with lithium prescriptions
How Lithium Actually Works in the Brain
Despite decades of use, the full picture of how lithium stabilizes mood is still being filled in. The two best-established mechanisms involve signaling pathways inside neurons. One centers on an enzyme called GSK-3β, which influences cell survival, growth, and the strength of connections between neurons. Lithium inhibits this enzyme, and that inhibition appears to protect brain cells and modulate neurotransmitter activity. The other pathway involves a system that uses a molecule called inositol to relay signals; lithium depletes inositol, dampening overactive signaling that may contribute to mania.31PubMed. Lithium therapy and signal transduction
More recent research has expanded the list. Lithium appears to affect the immune system, influence biological rhythms, protect the structures that cap the ends of chromosomes, and support the energy-producing machinery inside cells.32PubMed Central. The Mechanisms of Lithium Action: The Old and New Findings The sheer number of systems lithium touches likely explains both its broad effectiveness and its broad side-effect profile. It also makes sense of something clinicians have long observed: the therapeutic range is not a simple dose-response curve where more drug always means more effect. Rather, there seems to be a zone where multiple pathways are modulated just enough, and pushing beyond that zone tips the balance toward harm faster than it adds benefit.